•
Dec 30, 2024

Ovid Therapeutics Q1 2025 Earnings Report

Expected Revenue:$33.3K
-44.5% YoY
Expected EPS:-$0.13
+40.9% YoY

Ovid Therapeutics

Ovid Therapeutics